Roche Holding AG - H69293217
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aristotle Capital Management, LLC | History | Reduced | 218,992 | 90,720 | 0.18% | 0.14% | 1 | -2,246 | -1.02% | Q4 2025 | Feb 17, 2026 |
| Generali Investments CEE, investicni spolecnost, a.s. | History | Added to | 6,871 | 2,846 | 0.2% | 0.16% | 2 | +233 | 3.51% | Q4 2025 | Jan 14, 2026 |
| Boston Common Asset Management, LLC | History | Closed out | 0 | 0 | — | 0.79% | — | -86,719 | -100.0% | Q3 2025 | Oct 30, 2025 |
| Saranac Partners Ltd | History | Closed out | 0 | 0 | — | 0.03% | — | -520 | -100.0% | Q3 2025 | Dec 05, 2025 |